[Clinical considerations on a new synthetic compound with antipyretic and anticatarrhal action].
A Broncaspin suspension was administered for an average of 6-7 days (1/2 teaspoonful twice a day to patients up to 3 yr old; 1 teaspoonful twice a day to those over 3) in the treatment of acute febrile diseases of the upper airways in 16 male and 14 female children aged 5 months to 5 and 3/12 yr. Satisfactory results were obtained in all cases.